1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Apr 2024
Admin
News Article

BGI Genomics Launches Spearheading Innovation in Uruguay

BGI Genomics Launches First Clinical Laboratory in Uruguay, Spearheading Innovation

Overview

BGI Genomics, a renowned leader in precision medicine solutions, has launched a cutting-edge clinical laboratory in Uruguay's Parque de las Ciencias free trade zone. This move is poised to advance preventive healthcare throughout Latin America, employing state-of-the-art technology for early disease detection.

Figures Present at the Ceremony

The opening ceremony saw the presence of notable figures including Omar Paganini, Minister of Foreign Affairs; Elisa Facio, Minister of Industry, Energy, and Mining; and Karina Rando, Minister of Public Health, alongside other national and departmental dignitaries.
Dr. Yin Ye, CEO of BGI Group, the parent company of BGI Genomics, also attended.
Minister Rando had previously visited the site in August 2023, and Minister Facio had met with Dr. Yin Ye in China in November 2023.

BGI Genomics Library

This groundbreaking laboratory, spanning 1,000 square meters, is solely dedicated to BGI Genomics' operations, specializing in precision medicine applications.
It features a Huo-Yan Air Laboratory equipped with seven cabins, covering the entire genetic testing process.
Notable features include an advanced HVAC system and design elements to prevent contamination between cabins.

Current Workforce

The current workforce comprises Uruguayan technicians specializing in biochemistry and biotechnology, supplemented by application experts from China who provide training on the latest technologies.

Key Achievement

A key achievement of BGI Genomics is the development of Next-Generation Sequencing (NGS) technology, aimed at enhancing accessibility and affordability of genetic testing across Latin America.

Key Persons on the The Laboratory

Elisa Facio, Minister of Industry, Energy, and Mining, expressed excitement about Uruguay's potential in the biotechnology sector, with the launch of BGI Genomics' laboratory being a significant step forward.
Natalia Pereiras, laboratory director, highlighted the goal of making advanced diagnostic tools accessible at an affordable cost, achieved through in-house product and methodology development.
Wu Liang, general manager for Latin America at BGI Genomics, emphasized Uruguay's strategic advantages, leveraging its proximity to Carrasco Airport and the benefits of operating within a free trade zone.

Oncology Portfolio

BGI Genomics' extensive oncology portfolio includes COLOTECT, a Real-Time PCR-based product for detecting colorectal cancer. Additionally, the SENTIS portfolio aids clinicians in selecting optimal treatments for cancer patients.

Other Areas of Focus

Reproductive health is another focus area, with products like NIFTY offering prenatal screening from the tenth week of gestation, providing crucial insights into chromosomal abnormalities and disorders.
NIFTY Pro enhances screening capabilities, detecting a broader range of conditions including DiGeorge syndrome.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!